all stories

Lantheus Announces FDA Approval of TAUKLARIFY™ (Florquinitau F 18 Injection), an F18-Labeled Tau PET Imaging Agent for Alzheimer’s Disease

One daysingle sourceOne outlet reported this, once - no second voice in this corpus.
All 1 reports on Fri, 14 August 2026

What it is about

Mark KinarneyMary Anne HeinoKeith JohnsonAlzheimer AssociationDrug AdministrationHarvard Medical SchoolTerms Of ServiceExchange CommissionPharma SolutionsSecurities ExchangeManila, Manila, PhilippinesBedford, Massachusetts, United StatesUnited KingdomSwedenCanadaMassachusetts, United StatesNew Jersey, United StatesGermanySwitzerland

Who published it, and when

How it spread - 1 original report

  1. Fri, 14 August 2026

    1 report

One email a week

The stories everytrace watched stay alive - how many independent outlets carried each one, and how long it lasted. No daily digest, no breaking-news alerts.